Océanie · Actualité générale · The Mercury

Lunch Wrap: Nvidia’s drama gets a new episode as Xero grabs the popcorn

Publié par The Mercury · Australie il y a 13 h

Résumé détaillé

Clarity Pharmaceuticals (ASX:CU6) has scored the FDA’s first Breakthrough Therapy designation for a PSMA PET imaging agent, with its copper-64 SAR-bisPSMA scan showing promise in…

Lire l'article complet sur The Mercury Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.themercury.com.au)

Lunch Wrap: Nvidia’s drama gets a new episode as Xero grabs the popcorn

Résumé détaillé

À lire aussi

Council criticised for using AI to generate library mural

Council criticised for using AI to generate library mural

Council criticised for using AI to generate library mural

Sydneysiders warned after overseas passenger brings measles into city

Businesses could lose $590 million in R&D tax breaks under changes before the Senate. What’s the plan?

Addo-Carr free to leave Eels as club rejects extension opportunity

Lunch Wrap: Nvidia’s drama gets a new episode as Xero grabs the popcorn

Résumé détaillé

Partager

À lire aussi

Council criticised for using AI to generate library mural

Council criticised for using AI to generate library mural

Council criticised for using AI to generate library mural

Sydneysiders warned after overseas passenger brings measles into city

Businesses could lose $590 million in R&D tax breaks under changes before the Senate. What’s the plan?

Addo-Carr free to leave Eels as club rejects extension opportunity